4//SEC Filing
Deuel Thomas 4
Accession 0000930413-10-002212
CIK 0000727510other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 8:36 PM ET
Size
8.1 KB
Accession
0000930413-10-002212
Insider Transaction Report
Form 4
Deuel Thomas
Director
Transactions
- Award
Common Stock
2010-04-19+7,137→ 7,137 total - Award
Stock Option (right to buy)
2010-04-19−17,673→ 17,673 totalExercise: $10.51Exp: 2020-04-19→ Common Stock (17,673 underlying)
Footnotes (4)
- [F1]Restricted stock units granted by Enzon Pharmaceuticals, Inc. ("Enzon") pursuant to Enzon's 2001 Stock Incentive Plan and qualified under Rule 16b-3(d).
- [F2]Of the 7,137 shares granted, 2,379 will vest on April 19, 2011, 2,379 will vest on April 19, 2012, and the remaining 2,379 will vest on April 19, 2013 so long as Dr. Deuel is a member of Enzon's board of directors on the above dates.
- [F3]Stock options granted by Enzon pursuant to Enzon's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d).
- [F4]Of the 17,673 options granted by Enzon, 5,891 will vest on April 19, 2011, 5,891 will vest on April 19, 2012, and the remaining 5,891 will vest on April 19, 2013 so long as Dr. Deuel is a member of Enzon's board of directors on the above dates.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001405880
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 8:36 PM ET
- Size
- 8.1 KB